Supreme Court Expected to Hold Off on Affordable Care Act Ruling
The House told the Supreme Court earlier this month that the Fifth Circuit court’s decision posed a “severe, immediate threat” to the orderly operation of health care markets.
Related Articles
FDA Grants Orphan Drug Designation to LQT-1213 to Treat Patients With Long QT Syndrome
The treatment aims to reduce prolonged QTc interval in patients with long QT syndrome.
Plozasiran May Help Reduce Cholesterol Levels in Patients With Mixed Hyperlipidemia
High cholesterol levels are known risk factors for atherosclerotic cardiovascular disease.
HER2-Targeted Treatments for NSCLC: Introducing Zongertinib
Currently, standard first-line chemotherapy with or without immunotherapy for patients with non-small-cell lung cancer (NSCLC) with HER2 mutations has limited efficacy.
Study Findings Suggest Use of Fedratinib as Treatment in the Second Line for Myelofibrosis
Fedratinib is an orally available, small molecule inhibitor of JAK-2 approved for treatment of myelofibrosis.
Op-Ed: Lower Prescription Drug Costs, Pass PBM Reform Legislation
Lowering prescription drug costs for patients, saving taxpayers money, helping small businesses level an anti-competitive playing field: all of this is at stake.
FDA Approves Nivolumab for the Treatment of Adult Patients With Resectable NSCLC
Nivolumab is the only PD-1 inhibitor to show statistically significant and clinically meaningful benefits in non-small cell lung cancer compared with chemotherapy.
Semaglutide Associated With Reduced Risk of Opioid Overdose in Patients With Type 2 Diabetes, Opioid Use Disorder
The weight loss drug continues to show promise in treating a variety of other conditions.
Lower Dose of IVIG Remains Effective in Treating Pediatric Immune Thrombocytopenia Compared With Higher Dose
By utilizing a lower dose, patients can avoid potential adverse events and high financial burden.
Cologuard Plus Receives FDA Approval For Non-Invasive Colorectal Cancer Screening
The new screening test provides an easier, convenient option for patients seeking to screen themselves for colorectal cancer.
Lymphoplasmacytic Lymphoma Vaccine Leads to Potential Clinical Benefit as Early Intervention
Patients exhibited improved disease-free progression with minimal adverse effects.